Among patients with FIGO stages I–II, MMR deficiency showed a trend for poor PFS (p = 0.081) and a significantly poorer prognostic value for OS (p = 0.018) (Figure 3G,H). Here, MRC1 is linked to hyperinsulinemic hypoglycemia, familial, 4.